PCN67 COST UTILITY ANALYSIS OF ALEMTUZUMAB COMPARED TO CHLORAMBUCIL IN UNTREATED PATIENTS WITH HIGH-RISK (17P-) CHRONIC LYMPHOCYTIC LEUKEMIA IN THE UNITED KINGDOM

✍ Scribed by AC Lloyd; A Valderrama; J Ferguson; L Gilmour; F Ravndal

• Book ID: 119597454
• Publisher: John Wiley and Sons
• Year: 2008
• Tongue: English
• Weight: 97 KB
• Volume: 11
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(10)66603-x